哈莫尼生物科技 HRMY
$33.11 +$0.64 (+1.97%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $33.00 -0.33%
开盘$32.70
昨收$32.47
当日区间$32.27 – $33.38
成交量787.2K
市值$1.94B
市盈率（TTM）11.0
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$261.28M+30.3% YoY
营业利润$89.32M+85.4% YoY
净利润$75.43M+89.6% YoY
摊薄每股收益$1.28+88.2% YoY
自由现金流$92.43M+16.5% YoY
经营现金流$92.43M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率75.4%
营业利润率24.0%
净利率18.9%
净资产收益率20.5%
资产收益率14.6%
投入资本回报率16.5%
流动比率3.48
负债/资产比率27.2%
现金及投资$667.79M
总负债$153.96M
净现金（净负债）$513.83M
自由现金流/营收37.0%
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $261.28M | $215.39M | $868.45M | $243.78M | $239.46M |
| 营业总收入 | $261.28M | $215.39M | $868.45M | $243.78M | $239.46M |
| 营业成本 | $63.20M | $44.51M | $198.34M | $68.55M | $59.65M |
| 毛利润 | $198.08M | $170.88M | $670.11M | $175.23M | $179.81M |
| 营业费用 | $108.77M | $133.58M | $461.64M | $136.67M | $114.32M |
| 销售及管理费用 | $62.17M | $64.20M | $272.05M | $86.74M | $59.36M |
| -销售及营销费用 | $34.12M | $31.69M | $119.51M | $29.18M | $29.55M |
| -管理费用 | $28.05M | $32.51M | $152.54M | $57.56M | $29.81M |
| 研发费用 | $46.60M | $69.38M | $189.59M | $49.93M | $54.96M |
| 营业利润 | $89.32M | $37.29M | $208.47M | $38.56M | $65.49M |
| 非经营性利息净收入（支出） | $4.00M | $2.52M | $7.28M | $2.31M | $2.11M |
| 非经营性利息收入 | $7.07M | $5.76M | $21.92M | $5.85M | $5.73M |
| 非经营性利息支出 | $3.07M | $3.23M | $14.65M | $3.55M | $3.62M |
| 其他收入（支出） | -$53,000.00 | -$127,000.00 | -$680,000.00 | -$105,000.00 | -$106,000.00 |
| 其他非经营性收入（支出） | -$53,000.00 | -$127,000.00 | -$680,000.00 | -$105,000.00 | -$106,000.00 |
| 税前利润 | $93.27M | $39.69M | $215.06M | $40.76M | $67.49M |
| 税费 | $17.83M | $7.20M | $56.38M | $18.27M | $16.63M |
| 净利润 | $75.43M | $32.49M | $158.69M | $22.49M | $50.87M |
| 持续经营利润 | $75.43M | $32.49M | $158.69M | $22.49M | $50.87M |
| 归属母公司净利润 | $75.43M | $32.49M | $158.69M | $22.49M | $50.87M |
| 归属普通股股东净利润 | $75.43M | $32.49M | $158.69M | $22.49M | $50.87M |
| 基本每股收益 | $1.30 | $0.56 | $2.76 | $0.39 | $0.88 |
| 摊薄每股收益 | $1.28 | $0.55 | $2.71 | $0.38 | $0.87 |
| 特殊收益（费用） | – | – | $0.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.37B | $1.27B | $1.27B | $1.27B | $1.21B |
| 流动资产合计 | $814.33M | $778.82M | $907.01M | $907.01M | $838.80M |
| 现金及现金等价物与短期投资 | $667.79M | $640.92M | $775.34M | $775.34M | $672.58M |
| -现金及现金等价物 | $549.77M | $589.40M | $752.50M | $752.50M | $647.00M |
| -短期投资 | $118.02M | $51.52M | $22.84M | $22.84M | $25.58M |
| 应收款 | $111.00M | $108.22M | $96.79M | $96.79M | $100.65M |
| -应收账款 | $111.00M | $108.22M | $96.79M | $96.79M | $100.65M |
| 预付资产 | $19.31M | $16.80M | $16.01M | $16.01M | $23.31M |
| 存货 | $6.36M | $5.28M | $5.36M | $5.36M | $6.88M |
| 其他流动资产 | $9.88M | $7.60M | $13.52M | $13.52M | $35.38M |
| 非流动资产合计 | $558.75M | $493.01M | $364.62M | $364.62M | $369.42M |
| 投资及预付款 | $294.67M | $229.56M | $107.13M | $107.13M | $105.83M |
| -可供出售证券 | $294.67M | $229.56M | $107.13M | $107.13M | $105.83M |
| 商誉及其他无形资产 | $77.50M | $83.46M | $89.42M | $89.42M | $95.38M |
| 一年以上递延资产 | $156.77M | $153.56M | $149.70M | $149.70M | $157.08M |
| 其他非流动资产 | $29.82M | $26.43M | $18.37M | $18.37M | $9.69M |
| 负债合计 | $373.84M | $361.48M | $401.41M | $401.41M | $373.10M |
| 流动负债合计 | $234.07M | $217.34M | $252.13M | $252.13M | $223.40M |
| 应付款 | $21.68M | $28.60M | $17.69M | $17.69M | $26.34M |
| -应付账款 | $21.68M | $28.60M | $17.69M | $17.69M | $26.34M |
| 一年内应计费用 | $169.13M | $150.11M | $191.04M | $191.04M | $161.30M |
| 短期债务及融资租赁负债 | $20.00M | $20.00M | $20.00M | $20.00M | $20.00M |
| -一年内到期债务 | $20.00M | $20.00M | $20.00M | $20.00M | $20.00M |
| 其他流动负债 | $11.17M | $11.91M | $4.96M | $4.96M | $825,000.00 |
| 非流动负债合计 | $139.77M | $144.14M | $149.28M | $149.28M | $149.69M |
| 长期债务及融资租赁负债 | $133.96M | $138.81M | $143.66M | $143.66M | $148.51M |
| -长期债务 | $133.96M | $138.81M | $143.66M | $143.66M | $148.51M |
| 其他非流动负债 | $5.81M | $5.32M | $5.62M | $5.62M | $1.19M |
| 股东权益合计 | $999.24M | $910.35M | $870.22M | $870.22M | $835.12M |
| 股东权益 | $999.24M | $910.35M | $870.22M | $870.22M | $835.12M |
| 股本 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| -普通股 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 | $1,000.00 |
| 资本公积 | $731.15M | $717.37M | $708.97M | $708.97M | $696.35M |
| 留存收益 | $268.82M | $193.39M | $160.90M | $160.90M | $138.42M |
| 不影响留存收益的损益 | -$727,000.00 | -$413,000.00 | $346,000.00 | $346,000.00 | $357,000.00 |
| 固定资产净值 | – | – | – | – | $1.44M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $92.43M | $27.76M | $348.20M | $126.15M | $108.73M |
| 持续经营经营活动现金流净额 | $92.43M | $27.76M | $348.20M | $126.15M | $108.73M |
| 持续经营净利润 | $75.43M | $32.49M | $158.69M | $22.49M | $50.87M |
| 折旧、折耗与摊销 | $5.97M | $5.97M | $25.34M | $7.43M | $5.97M |
| 递延税款 | -$3.20M | -$3.86M | -$7.30M | $7.38M | -$3.88M |
| 其他非现金项目 | $1.07M | $32.40M | $36.29M | $5.13M | $15.01M |
| 营运资金变动 | $4.25M | -$49.63M | $91.82M | $74.04M | $30.14M |
| -应收款变动 | -$2.77M | -$11.44M | -$13.75M | $3.86M | -$7.67M |
| -存货变动 | -$1.08M | $76,000.00 | $1.84M | $1.53M | -$782,000.00 |
| -预付资产变动 | -$7.85M | -$3.00M | $31.79M | $24.85M | $12.53M |
| -应付账款及应计费用变动 | -$6.92M | $10.91M | $3.95M | -$8.65M | -$1.96M |
| -其他流动负债变动 | $22.87M | -$46.18M | $67.99M | $52.45M | $28.03M |
| 投资活动现金流净额 | -$131.50M | -$183.65M | -$39.65M | -$17.63M | -$4.79M |
| 持续经营投资活动现金流净额 | -$131.50M | -$183.65M | -$39.65M | -$17.63M | -$4.79M |
| 固定资产购置及出售净额 | $0.00 | $0.00 | -$310,000.00 | -$107,000.00 | -$71,000.00 |
| 投资购置及出售净额 | -$131.50M | -$151.65M | -$5.09M | $1.72M | -$4.72M |
| 其他投资变动净额 | $0.00 | -$32.00M | -$15.00M | $0.00 | $0.00 |
| 筹资活动现金流 | -$558,000.00 | -$7.22M | -$9.05M | -$3.02M | -$3.00M |
| 持续经营筹资活动现金流净额 | -$558,000.00 | -$7.22M | -$9.05M | -$3.02M | -$3.00M |
| 债务发行及偿还净额 | -$5.00M | -$5.00M | -$16.25M | -$5.00M | -$3.75M |
| 股票期权行使所得 | $5.52M | $347,000.00 | $10.21M | $2.65M | $754,000.00 |
| 其他筹资费用净额 | -$1.08M | -$2.57M | -$3.00M | -$663,000.00 | $0.00 |
| 期末现金余额 | $550.04M | $589.67M | $752.77M | $752.77M | $647.27M |
| 现金净变动 | -$39.63M | -$163.10M | $299.50M | $105.50M | $100.95M |
| 期初现金余额 | $589.67M | $752.77M | $453.27M | $647.27M | $546.32M |
| 自由现金流 | $92.43M | $27.76M | $347.89M | $126.04M | $108.66M |
| 业务购买及出售净额 | – | – | -$19.25M | -$19.25M | – |
| 普通股发行净额 | – | – | $0.00 | – | – |
暂无评论——快来第一个聊聊 HRMY。
登录后参与讨论。